Quest Diagnostics Incorporated
Karthik Kuppusamy (SVP, Clinical Solutions) reports DGX insider transactions
AI-generated summary
Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics Incorporated, reported 33 shares in code L transactions on October 21, 2026, at an average price of $235.94 for a total value of $7,786.15. Following the transaction, the insider directly held 13,619 shares of common stock. No Rule 10b5-1 trading plan was used.
Key facts
- Insider
- Karthik Kuppusamy · SVP, Clinical Solutions
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | LFootnotes F1, F2 | +33 | $235.94 | $7,786.15 | 13,619 | Direct |
Footnotes
- F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
- F2 The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F3 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
More DGX filings
- 4
Filed Oct 28, 2026
- 144
Filed Oct 26, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.